Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
| 02-2023 | 11-2022 | 08-2022 | 06-2022 | 05-2022 | |
| Sales | 43 | 60 | 28 | 0 | 40 |
| Operating Expenses | -850 | 349 | 1,701 | 80 | 166 |
| Operating Income | 893 | -289 | -1,674 | -80 | -126 |
| Interest Expense | 27 | 28 | 14 | 5 | 6 |
| Other Income | -1,817 | 0 | -28 | 6 | 0 |
| Pre-tax Income | -951 | -317 | -1,715 | -78 | -132 |
| Income Tax | -6 | 0 | 0 | N/A | -3 |
| Net Income Continuous | -946 | -317 | -1,715 | -78 | -128 |
| Net Income | $-946 | $-317 | $-1,715 | $-78 | $-128 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.03 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.03 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.03 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.03 | -0.01 | 0.00 |
| EBITDA(a) | $-914 | $-278 | $-1,690 | $-73 | $-115 |